GLP-1 agonist – Globalstar International

Liraglutide (6mg/ml) Tablet

admin — Sun, 27 Jul 2025 05:18:15 +0000

Overview: Victoza Solution for Injection is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage type 2 diabetes. It contains Liraglutide, which helps to lower blood sugar by increasing insulin secretion, decreasing glucagon levels, and slowing gastric emptying. Key Benefits: – Effective blood sugar control – Reduces risk of cardiovascular events – May aid in weight loss Composition: Liraglutide (6mg/ml) How It Works: Liraglutide mimics the GLP-1 hormone, enhancing insulin secretion only when needed and suppressing glucagon release, thereby improving glycemic control. Usage Instructions: – Inject once daily, at any time of the day, independent of meals – Administer subcutaneously in the abdomen, thigh, or upper arm – Follow the prescribed dosage and duration Side Effects: – Nausea or vomiting – Constipation or diarrhea – Low blood sugar (especially with other anti-diabetics) Precautions: – Not for use in type 1 diabetes or DKA – Caution in patients with a history of thyroid tumors – Avoid during pregnancy or breastfeeding unless advised by doctor Storage Instructions: – Store in a refrigerator (2 – 8°C) – Do not freeze Manufacturer: Novo Nordisk India Pvt Ltd Disclaimer: This content is for informational purposes only. Please consult your healthcare provider before using any medication.

Semaglutide (14mg) Tablet

admin — Sun, 27 Jul 2025 05:18:11 +0000

Overview: Rybelsus 14mg Tablet is an oral GLP-1 receptor agonist used to manage blood glucose levels in adults with type 2 diabetes. It contains Semaglutide, which enhances insulin secretion and lowers glucagon levels, improving glycemic control. Key Benefits: – Oral GLP-1 therapy – Helps in weight reduction – Improves blood sugar control Composition: Semaglutide (14mg) How It Works: Semaglutide mimics the action of the GLP-1 hormone, stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying. Usage Instructions: – Take on an empty stomach with a small amount of water – Wait at least 30 minutes before eating or drinking anything else – Follow the dosage schedule as advised by your physician Side Effects: – Nausea or vomiting – Diarrhea or abdominal discomfort – Headache or dizziness Precautions: – Not for type 1 diabetes or DKA – Monitor kidney function in patients with dehydration – Avoid during pregnancy or breastfeeding without doctor consultation Storage Instructions: – Store below 30°C Manufacturer: Novo Nordisk India Pvt Ltd Disclaimer: This content is for informational purposes only. Please consult your healthcare provider before using any medication.

Dulaglutide (1.5mg/0.5ml) Tablet

admin — Sun, 27 Jul 2025 05:18:04 +0000

Overview: Trulicity 1.5mg Pre-Filled Pen is used to treat adults with type 2 diabetes mellitus. It contains Dulaglutide, a GLP-1 receptor agonist that helps lower blood sugar levels and reduce the risk of cardiovascular events. Key Benefits: – Weekly injectable for blood sugar control – Helps with weight management – Cardiovascular protection Composition: Dulaglutide (1.5mg/0.5ml) How It Works: Dulaglutide mimics the action of GLP-1, stimulating insulin secretion, reducing glucagon release, and slowing gastric emptying. Usage Instructions: – Inject subcutaneously once a week on the same day each week – Administer in abdomen, thigh, or upper arm – Follow physician’s advice for dose and schedule Side Effects: – Nausea or vomiting – Diarrhea or constipation – Abdominal pain – Fatigue or low appetite Precautions: – Not for use in type 1 diabetes or DKA – Avoid if history of thyroid carcinoma – Monitor for pancreatitis symptoms Storage Instructions: – Store in a refrigerator (2 – 8°C) – Do not freeze Manufacturer: Eli Lilly and Company India Pvt Ltd Disclaimer: This content is for informational purposes only. Please consult your healthcare provider before using any medication.